Japan Science & Technology Agency
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 6, 2026), Japan Science & Technology Agency reported 12 stock positions worth $5.4 billion. Its top holding was Ishr Ibx Usd Invgd CB ETF-Ui (LQD) at 20.9% of the portfolio, followed by Ishr Ibx Usd Hiyld CB ETF-Ui (HYG, 15.4%) and iShares Core S&P 500 ETF (IVV, 14.7%). Compared with Q3 2025, it sold out of 1, added to 3 and reduced 1. The biggest buy was iShares Core MSCI Emerging (IEMG, shares +179%) and the biggest sale Ishr Ibx Usd Invgd CB ETF-Ui (LQD, shares −22%).
- Most Recent 13F
- Q2 2026
- Location
- TOKYO, M0
- CIK
- 0001948391
- Portfolio Value
- $5.4B (Q4 2025)
- SEC Filing
- 0001948391-26-000002 ↗ filed Feb 6, 2026
Holdings Value
Holdings 12 stocks · $5.4B
| LQD Ishr Ibx Usd Invgd CB ETF-Ui | 20.87% | 10,306,450 | $1.1B | Reduce -22.0% |
| HYG Ishr Ibx Usd Hiyld CB ETF-Ui | 15.39% | 10,390,626 | $837.8M | No change |
| IVV iShares Core S&P 500 ETF | 14.73% | 1,170,800 | $801.9M | No change |
| RSP Invesco S&P 500 Equal Weight | 13.35% | 3,792,112 | $726.4M | No change |
| USHY iShares Broad Usd High Yield | 9.84% | 14,319,906 | $535.5M | Add +11.7% |
| JNK SS SPDR BB High Yield Bond | 5.18% | 2,900,000 | $281.9M | No change |
| QQQ Invesco QQQ Trust Series 1 | 4.55% | 403,081 | $247.6M | Add +35.0% |
| EMB iShares JP Morgan Usd Emergi | 4.42% | 2,500,000 | $240.7M | No change |
| IEMG iShares Core MSCI Emerging | 3.77% | 3,050,554 | $205.1M | Add +178.7% |
| SHYG iShares 0-5 YR HY Corp. Bond | 3.50% | 4,450,000 | $190.8M | No change |
| VUG Vanguard Mrngstar GR ETF-Sui | 3.15% | 350,953 | $171.2M | No change |
| VTV Vanguard Mrngstr Val ETF-Aui | 1.25% | 357,328 | $68.2M | No change |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $5.3B | HYG, LQD, IVV, RSP, USHY |
| Q1 2026 | 12 | $4.8B | LQD, HYG, IVV, RSP, USHY |
| Q4 2025 | 12 | $5.4B | LQD, HYG, IVV, RSP, USHY |
| Q3 2025 | 13 | $5.6B | LQD, HYG, IVV, RSP, USHY |
| Q2 2025 | 13 | $6.3B | LQD, HYG, IVV, RSP, VCIT |
| Q1 2025 | 13 | $6.5B | LQD, HYG, IVV, RSP, VCIT |
| Q4 2024 | 11 | $5.8B | LQD, HYG, VCIT, VCSH, IGSB |
| Q3 2024 | 13 | $7.6B | LQD, VCSH, VCIT, HYG, IGSB |
| Q2 2024 | 12 | $7.2B | LQD, VCSH, VCIT, HYG, IGSB |
| Q1 2024 | 12 | $8.1B | VCSH, LQD, VCIT, HYG, IGSB |